These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1493874)

  • 21. [Effect of chemotherapy on the Schistosoma mansoni eggs].
    dos Reis MG; Andrade ZA
    Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genomic change associated with the development of resistance to hycanthone in Schistosoma mansoni.
    Brindley PJ; Lewis FA; McCutchan TF; Bueding E; Sher A
    Mol Biochem Parasitol; 1989 Oct; 36(3):243-52. PubMed ID: 2571929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
    Coelho PM; Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Mol Biochem Parasitol; 1988 Oct; 31(1):87-96. PubMed ID: 3185615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population.
    Chevalier FD; Le Clec'h W; Eng N; Rugel AR; Assis RR; Oliveira G; Holloway SP; Cao X; Hart PJ; LoVerde PT; Anderson TJ
    Int J Parasitol; 2016 Jun; 46(7):417-24. PubMed ID: 27073078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of oxamniquine on Schistosoma mansoni in experimentally infected mice].
    Kohn A; Serapiao CJ; Katz N; Dias EP
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):217-27. PubMed ID: 549207
    [No Abstract]   [Full Text] [Related]  

  • 30. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
    Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
    [No Abstract]   [Full Text] [Related]  

  • 31. A study of the mode of action of hycanthone against Schistosoma mansoni in vivo and in vitro.
    Cioli D; Knopf PM
    Am J Trop Med Hyg; 1980 Mar; 29(2):220-6. PubMed ID: 7369442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites.
    Valentim CL; Cioli D; Chevalier FD; Cao X; Taylor AB; Holloway SP; Pica-Mattoccia L; Guidi A; Basso A; Tsai IJ; Berriman M; Carvalho-Queiroz C; Almeida M; Aguilar H; Frantz DE; Hart PJ; LoVerde PT; Anderson TJ
    Science; 2013 Dec; 342(6164):1385-9. PubMed ID: 24263136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the mode of antischistosomal action of hycanthone.
    Cioli D; Pica-Mattoccia L; Rosenberg S; Archer S
    Life Sci; 1985 Jul; 37(2):161-7. PubMed ID: 4010473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study on the genetic effects of hycanthone and oxamniquine.
    Ray VA; Holden HE; Ellis JH; Hyneck ML
    J Toxicol Environ Health; 1975 Nov; 1(2):211-7. PubMed ID: 1107579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schistosoma mansoni: the survival and reproductive status of mature infections in mice treated with oxamniquine.
    Popiel I; Erasmus DA
    J Helminthol; 1982 Sep; 56(3):257-61. PubMed ID: 7175165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a programmed alteration in an 18S ribosomal gene that accompanies the experimental induction of drug resistance in Schistosoma mansoni.
    Brindley PJ; Heath S; Waters AP; McCutchan TF; Sher A
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7754-8. PubMed ID: 1679236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient linkage mapping using exome capture and extreme QTL in schistosome parasites.
    Chevalier FD; Valentim CL; LoVerde PT; Anderson TJ
    BMC Genomics; 2014 Jul; 15(1):617. PubMed ID: 25048426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
    Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.